RS49904B - Pseudopolimorfni oblici 2-[2-[ 4- [bis( 4-fluorofenil)metil]-1-piperazinil]etoksi] sirćetne kiseline dihidrohlorida - Google Patents

Pseudopolimorfni oblici 2-[2-[ 4- [bis( 4-fluorofenil)metil]-1-piperazinil]etoksi] sirćetne kiseline dihidrohlorida

Info

Publication number
RS49904B
RS49904B YUP-316/00A YU31600A RS49904B RS 49904 B RS49904 B RS 49904B YU 31600 A YU31600 A YU 31600A RS 49904 B RS49904 B RS 49904B
Authority
RS
Serbia
Prior art keywords
piperazinyl
fluorophenyl
ethoxy
bis
methyl
Prior art date
Application number
YUP-316/00A
Other languages
English (en)
Inventor
Monique BERWAER
Guy Bodson
Michel DELEERS
Charles DOGIMONT
Domenico Fanara
Jacques TIMMERMANS
Original Assignee
Ucb S.A.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb S.A., filed Critical Ucb S.A.,
Publication of YU31600A publication Critical patent/YU31600A/sh
Publication of RS49904B publication Critical patent/RS49904B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1.Anhidrovandihidrohlorid2-[2- [4-[bis( 4- t1uorofenil)metil] -l-piperazinil]etoksi] -sirćetnekiseline koji je okarakterisan time što su u difraktogramu X-zraka praha prisutni pikovi na 20 vrednostima: 13,70±0.5; 13,9°.±0.5; 16,3°±0.5; 18,0°.±0.5; 18,6°.±0.5; 19,1°±0.5; 23,10±0.5; 24,1°.±0.5; 25,6°±0.5 i 30,2°±0.5.
YUP-316/00A 1997-11-26 1998-11-26 Pseudopolimorfni oblici 2-[2-[ 4- [bis( 4-fluorofenil)metil]-1-piperazinil]etoksi] sirćetne kiseline dihidrohlorida RS49904B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97870193A EP0919550A1 (en) 1997-11-26 1997-11-26 Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride

Publications (2)

Publication Number Publication Date
YU31600A YU31600A (sh) 2002-03-18
RS49904B true RS49904B (sr) 2008-08-07

Family

ID=8231072

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-316/00A RS49904B (sr) 1997-11-26 1998-11-26 Pseudopolimorfni oblici 2-[2-[ 4- [bis( 4-fluorofenil)metil]-1-piperazinil]etoksi] sirćetne kiseline dihidrohlorida

Country Status (39)

Country Link
US (2) US6262057B1 (sr)
EP (2) EP0919550A1 (sr)
JP (2) JP3996348B2 (sr)
KR (1) KR100557711B1 (sr)
CN (1) CN100406448C (sr)
AR (1) AR017676A1 (sr)
AT (1) ATE203237T1 (sr)
AU (1) AU735819B2 (sr)
BG (1) BG64155B1 (sr)
BR (1) BR9815405A (sr)
CA (1) CA2310318C (sr)
CO (1) CO4980892A1 (sr)
CZ (1) CZ295972B6 (sr)
DE (1) DE69801163T2 (sr)
DK (1) DK1034171T3 (sr)
EG (1) EG23776A (sr)
ES (1) ES2161552T3 (sr)
GC (1) GC0000094A (sr)
GR (1) GR3036702T3 (sr)
HU (1) HUP0100343A3 (sr)
ID (1) ID24964A (sr)
IL (1) IL135544A (sr)
MA (1) MA26569A1 (sr)
MY (1) MY119653A (sr)
NO (1) NO314692B1 (sr)
NZ (1) NZ504461A (sr)
PE (1) PE134899A1 (sr)
PL (1) PL190871B1 (sr)
PT (1) PT1034171E (sr)
RS (1) RS49904B (sr)
RU (1) RU2182575C2 (sr)
SI (1) SI20325A (sr)
SK (1) SK283237B6 (sr)
TN (1) TNSN98214A1 (sr)
TR (1) TR200001505T2 (sr)
TW (1) TWI225053B (sr)
UA (1) UA54568C2 (sr)
WO (1) WO1999028310A1 (sr)
ZA (1) ZA9810780B (sr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002221854A1 (en) * 2000-12-15 2002-06-24 U C B, S.A. Use of cetirizine or efletirizine for preventing urticaria
AU2002325355B8 (en) * 2001-07-26 2007-10-25 Ucb Process for the preparation of 2-(2-(4-BIS(4-fluorophenyl)methyl-piperazin-1-YL)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor
US20050181032A1 (en) * 2002-06-25 2005-08-18 Acrux Dds Pty Ltd. Metastable pharmaceutical compositions
KR20050045946A (ko) 2002-06-25 2005-05-17 애크럭스 디디에스 피티와이 리미티드 비정질 약학적 조성물을 이용한 경피전달속도의 제어
JP2007500197A (ja) * 2003-05-28 2007-01-11 ユセベ ファルシム ソシエテ アノニム 持続性アレルギー性鼻炎の治療のためのエフレチリジンの使用
WO2006050909A1 (en) * 2004-11-10 2006-05-18 Ucb Farchim Sa Novel forms of efletirizine dihydrochloride, processes for making them and pharmaceutical compositions including them
WO2008155777A2 (en) * 2007-06-18 2008-12-24 Cadila Healthcare Limited Process for preparing efletrizine
KR101006760B1 (ko) * 2008-07-17 2011-01-11 주식회사 진영테크 모터 순간 정전 복원 장치

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH505116A (it) * 1966-11-21 1971-03-31 Crc Ricerca Chim Metodo per l'ottenimento di derivati della piperazina
SE409706B (sv) 1976-05-21 1979-09-03 Astra Pharma Prod Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat
JPS57149282A (en) * 1981-02-06 1982-09-14 Ucb Sa 2-(4-(diphenylmethyl)-1-piperazinyl)acetic acid and their derivatives as medicine
NO155805C (no) * 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
GB8827391D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
GB8827390D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
US5625358A (en) * 1993-09-13 1997-04-29 Analog Devices, Inc. Digital phase-locked loop utilizing a high order sigma-delta modulator
BE1010094A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Nouveaux [2-(1-piperazinyl)ethoxy] methyle substitues.
BE1010095A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Procede de preparation de l'acide 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl] ethoxy]-acetique et de ses sels.

Also Published As

Publication number Publication date
BG104424A (en) 2001-01-31
US6262057B1 (en) 2001-07-17
KR20010032420A (ko) 2001-04-16
IL135544A0 (en) 2001-05-20
AU735819B2 (en) 2001-07-19
TWI225053B (en) 2004-12-11
EP1034171B1 (en) 2001-07-18
CA2310318A1 (en) 1999-06-10
SK283237B6 (sk) 2003-04-01
ES2161552T3 (es) 2001-12-01
CO4980892A1 (es) 2000-11-27
JP2001524548A (ja) 2001-12-04
SI20325A (sl) 2001-02-28
ZA9810780B (en) 1999-05-31
US6335331B2 (en) 2002-01-01
RU2182575C2 (ru) 2002-05-20
GR3036702T3 (en) 2001-12-31
JP2007224042A (ja) 2007-09-06
PL190871B1 (pl) 2006-02-28
HUP0100343A3 (en) 2001-09-28
US20010021712A1 (en) 2001-09-13
TNSN98214A1 (fr) 2005-03-15
GC0000094A (en) 2005-06-29
AR017676A1 (es) 2001-09-12
CA2310318C (en) 2003-10-21
JP3996348B2 (ja) 2007-10-24
PE134899A1 (es) 2000-01-11
DE69801163T2 (de) 2002-03-28
MA26569A1 (fr) 2004-12-20
EP1034171A1 (en) 2000-09-13
EG23776A (en) 2007-08-08
CN100406448C (zh) 2008-07-30
DE69801163D1 (en) 2001-08-23
CN1279676A (zh) 2001-01-10
ATE203237T1 (de) 2001-08-15
EP0919550A1 (en) 1999-06-02
CZ20001787A3 (cs) 2000-09-13
HUP0100343A2 (hu) 2001-07-30
ID24964A (id) 2000-08-31
YU31600A (sh) 2002-03-18
NZ504461A (en) 2001-06-29
UA54568C2 (uk) 2003-03-17
BG64155B1 (bg) 2004-02-27
CZ295972B6 (cs) 2005-12-14
BR9815405A (pt) 2000-10-10
NO20002631D0 (no) 2000-05-23
IL135544A (en) 2004-02-08
KR100557711B1 (ko) 2006-03-07
PL340724A1 (en) 2001-02-26
NO20002631L (no) 2000-05-23
PT1034171E (pt) 2001-11-30
AU1327799A (en) 1999-06-16
TR200001505T2 (tr) 2000-09-21
NO314692B1 (no) 2003-05-05
SK5942000A3 (en) 2000-10-09
MY119653A (en) 2005-06-30
DK1034171T3 (da) 2001-11-05
WO1999028310A1 (en) 1999-06-10

Similar Documents

Publication Publication Date Title
TR200102360T2 (tr) Tert-butil(E)- (6[2-[4-(4-fluorofenil)-6-izopropil-2-[metil (metilsulfonil)amino]pirimidin-5-il] (4R,6S)-2, 2-dimetil[1,3]dioksan-4-il)asetatın üretim için işlem.
FI964815A0 (fi) Piperatsiinijohdoksia 5-HT1A antagonisteina
IT1312115B1 (it) Composti amorfi e relative composizioni farmaceutiche
RS49904B (sr) Pseudopolimorfni oblici 2-[2-[ 4- [bis( 4-fluorofenil)metil]-1-piperazinil]etoksi] sirćetne kiseline dihidrohlorida
DE69706825T2 (de) Pharmazeutische zusammensetzung gegen durch papillomaviren verursachte tumoren und infektionen
DK0481744T3 (da) Piperazinderivater
DE69414194T2 (de) Aminosäurederivate und ihre Verwendung als Enkephalinase-Inhibitoren
NO20004545D0 (no) FremgangsmÕte for fremstilling av (R)-<alfa>-(2,3- dimetoksyfenyl)-1-[2-(4-fluorofenyl)etyl]-4-piperidinmetanol
HU9700744D0 (en) Process for the manufacture of 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]-ethoxy]-acetic acid and its salts
US5563157B1 (en) Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
HUP0000934A3 (en) 4-{2-[n-(3-phenoxy-2-hydroxy)propylamino]-ethyl}-anilide derivatives and pharmaceutical compositions thereof
MXPA03006534A (es) Metodo para obtener (3-ciano-1h-indol-7-il)-(4(4- fluorfenetil)-piperazin-1-il)-metanona y sus sales.
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
ATE63309T1 (de) 2,3-dihydro-2-oxo-3-benzofuranylessigs|urederivate und diese enthaltende arzneimittel.
MY110446A (en) Piperazine derivatives
ECSP972089A (es) Sal mesilato trihidrato de 5-[2-[4(1,2-benzoisotiazol-3-il]-1-piperazinil)etil]-6-cloro- 1,3- dihidro- 2h- inddol - 2 - ona